{"id":39248,"date":"2026-07-29T09:56:00","date_gmt":"2026-07-29T13:56:00","guid":{"rendered":"https:\/\/www.drugpatentwatch.com\/blog\/shionogi-inc-v-lupin-limited\/"},"modified":"2026-06-17T02:15:33","modified_gmt":"2026-06-17T06:15:33","slug":"shionogi-inc-v-lupin-limited","status":"publish","type":"post","link":"https:\/\/www.drugpatentwatch.com\/blog\/shionogi-inc-v-lupin-limited\/","title":{"rendered":"SHIONOGI INC. v. LUPIN LIMITED"},"content":{"rendered":"<h2>SHIONOGI v. LUPIN (2:26-cv-06218): Litigation Summary, Patent Estate Impact, and Generic Launch Risk<\/h2>\n<p>Shionogi Inc. v. Lupin Limited, case number 2:26-cv-06218, is a US Hatch-Waxman-style patent litigation matter. The litigation record is not provided in the prompt, so a complete, accurate litigation summary (asserted patents, claims, procedural posture, dates, and outcome) cannot be produced.<\/p>\n<h2>What is the case status in SHIONOGI INC. v. LUPIN LIMITED 2:26-cv-06218?<\/h2>\n<p>No litigation details are included in the provided input (no docket status, motions schedule, hearing dates, or final orders). A status summary cannot be stated.<\/p>\n<h3>What procedural stage is the case in?<\/h3>\n<p>No complaint, answer, scheduled deadlines, or case management order information is provided.<\/p>\n<h3>When was the lawsuit filed?<\/h3>\n<p>The filing date is not provided in the input, beyond the case number.<\/p>\n<h2>Which patents are asserted in SHIONOGI v. LUPIN 2:26-cv-06218?<\/h2>\n<p>The asserted patent numbers and claims are not included in the provided input. A patent-assertion map cannot be generated.<\/p>\n<h3>What is the Orange Book hook for the asserted patents?<\/h3>\n<p>No drug name, NDA\/BLA number, or Orange Book listing is provided.<\/p>\n<h3>Are formulation patents, method-of-use patents, or manufacturing patents asserted?<\/h3>\n<p>No claim types or patent classifications are provided.<\/p>\n<h2>What FDA Paragraph IV certification and ANDA\/BLA context drives SHIONOGI v.\u2026<\/h2>","protected":false},"excerpt":{"rendered":"<p>SHIONOGI v. LUPIN (2:26-cv-06218): Litigation Summary, Patent Estate Impact, and Generic Launch Risk Shionogi Inc. v. Lupin Limited, case number [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":34556,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"class_list":["post-39248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=39248"}],"version-history":[{"count":1,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39248\/revisions"}],"predecessor-version":[{"id":39379,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39248\/revisions\/39379"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/34556"}],"wp:attachment":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media?parent=39248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/categories?post=39248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/tags?post=39248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}